Mesothelioma surgery: Difference between revisions

Jump to navigation Jump to search
Line 5: Line 5:
==Surgery==
==Surgery==
*Surgery, either by itself or used in combination with pre- and post-operative adjuvant therapies has proved disappointing.  
*Surgery, either by itself or used in combination with pre- and post-operative adjuvant therapies has proved disappointing.  
*A pleurectomy/decortication is the most common surgery, in which the lining of the chest is removed. Less common is an extrapleural pneumonectomy (EPP), in which the lung, lining of the inside of the chest, the hemi-[[Thoracic diaphragm|diaphragm]] and the [[pericardium]] are removed. It is not possible to remove the entire mesothelium without killing the patient.
*A pleurectomy/decortication is the most common surgery, in which the lining of the chest is removed.  
 
*Less common is an extrapleural pneumonectomy (EPP), in which the lung, lining of the inside of the chest, the hemi-[[Thoracic diaphragm|diaphragm]] and the [[pericardium]] are removed.  
:*[[Pleurodesis]] and [[pleurectomy]] can be used to manage bothersome effusions
*It is not possible to remove the entire mesothelium without killing the patient.
:*Radical pneumonectomy with removal of the lung, [[pleura]], [[pericardium]], [[phrenic nerve]] and the hemidiaphragm has an almost 35% operative mortality, but with adjuvant [[chemotherapy]] and radiation may prolong survival and palliate severe dyspnea
*[[Pleurodesis]] and [[pleurectomy]] can be used to manage bothersome effusions
 
*Radical pneumonectomy with removal of the lung, [[pleura]], [[pericardium]], [[phrenic nerve]] and the hemidiaphragm has an almost 35% operative mortality, but with adjuvant [[chemotherapy]] and radiation may prolong survival and palliate severe dyspnea
Median survival increased from 16 to 24 months
*Median survival increased from 16 to 24 months


==References==
==References==

Revision as of 18:10, 13 January 2016

Mesothelioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mesothelioma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Diagnostic Studies

Other Imaging Findings

Treatment

Medical Therapy

Surgery

Summary of Treatment for Pleural Mesothelioma

Summary of Treatment for Peritoneal Mesothelioma

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mesothelioma surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mesothelioma surgery

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mesothelioma surgery

CDC on Mesothelioma surgery

Mesothelioma surgery in the news

Blogs on Mesothelioma surgery

Directions to Hospitals Treating Mesothelioma

Risk calculators and risk factors for Mesothelioma surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1][{AE}}Parminder Dhingra, M.D. [2]

Overview

Surgery

  • Surgery, either by itself or used in combination with pre- and post-operative adjuvant therapies has proved disappointing.
  • A pleurectomy/decortication is the most common surgery, in which the lining of the chest is removed.
  • Less common is an extrapleural pneumonectomy (EPP), in which the lung, lining of the inside of the chest, the hemi-diaphragm and the pericardium are removed.
  • It is not possible to remove the entire mesothelium without killing the patient.
  • Pleurodesis and pleurectomy can be used to manage bothersome effusions
  • Radical pneumonectomy with removal of the lung, pleura, pericardium, phrenic nerve and the hemidiaphragm has an almost 35% operative mortality, but with adjuvant chemotherapy and radiation may prolong survival and palliate severe dyspnea
  • Median survival increased from 16 to 24 months

References


Template:WikiDoc Sources